Recursive Superintelligence, the startup trying to build AI that improves itself, has released its first model. Flint is a free coding model small enough to run on a laptop. Recursive says its own ...

Artificial intelligence is widely used to develop software, analyze research, and improve the tools that power the technology itself. Recursive, an AI startup focused on building systems that can ...

PROVIDENCE, R.I. (WPRI) — Independent gubernatorial candidate Ken Block is upping the pressure on Republican rival Aaron Guckian to quit the race with the release of an internal poll, but Guckian says ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Earlier this year, Rishub Jain left his position as an artificial intelligence researcher at Google DeepMind after a revelation. As he worked on new models, he came to believe that he and everyone ...

Washington — A federal judge on Friday extended her block on the U.S. Postal Service's new requirements for mail voting, as states prepare to begin sending mail ballots to voters for the November ...

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...

Michael Block was a hot topic Sunday on social media. Now 50, Block was competing at the Staysure PGA Seniors Championship at Trump International Golf Links in Aberdeen, Scotland before withdrawing ...

It’s the senior tour DQ heard ’round the world, if such a thing exists. Michael Block’s disqualification from the Staysure PGA Seniors Championship in Aberdeen, Scotland was not just shocking because ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.